INTRODUCTION

Thrombospondin-1 (TSP)
1 represents 20-30% of the glycoproteins stored in human platelet α-granules (1).
Upon platelet activation and degranulation, TSP is released, and an important fraction is found associated with the platelet surface (2, 3) . Several putative receptors and ligands for TSP at the surface of activated platelets have been described, including fibrinogen (Fg) (4-7), sulfatides (8) glycoprotein IV (GPIV, CD36) (9, 10) and integrin associated protein (IAP/CD47) (11) . TSP may also interact with several integrins including αvβ3 and αIIbβ3
(GPIIbIIIa), through its cryptic Arg-Gly-Asp-Ala (RGDA) sequences (12) . However the interaction of TSP with
GPIIbIIIa is controversial (13) (14) (15) (16) (17) .
The participation of TSP in platelet aggregation has been demonstrated by a variety of studies reporting inhibition of platelet aggregation and secretion, by anti-TSP antibodies (18) (19) (20) (21) (22) (23) and synthetic or recombinant peptides of TSP (6, 24) . Leung (1984) (19) suggested that the interaction of TSP with Fg on the surface of activated platelets stabilizes the binding of Fg to its receptor, the activated integrin GPIIbIIIa (GPIIbIIIa*), with only Fg participating in direct cross-bridges. Recent studies propose that TSP also interacts with the integrin associated protein (IAP/CD47) (11) and functions as a costimulator of platelet integrin GPIIbIIIa and GPIaIIa (25, 26) . A direct role for TSP as a cross-linker of platelets involving TSP-Fg interactions was supported by studies performed with isolated platelet membranes or activated fixed platelets (AFP) bearing Fg (27, 28) . However in these models, the correlation between numbers of ligands/receptors and kinetics/extent of aggregation was not addressed. Moreover, studies were generally performed under nearly static conditions (29) or in an aggregometer (27) , i.e. non representative of the physiological flow environment and shear stresses.
In the present study, using well defined in flow-experimental models, free of plasma, red blood cells, platelet signalling and secretion, we isolated, measured and modelled i) the capacity of TSP to form and support inter-platelet cross-bridges through its interactions with Fg or with other TSP molecules, and ii) the contribution of TSP-mediated cross-bridges in the aggregation of platelets driven by Fg/GPIIbIIIa* interactions.
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EXPERIMENTAL PROCEDURES
Reagents. Human platelet thrombospondin (TSP) was purified as published (30) and characterized by western blot for the absence of fibrinogen, von Willebrand factor and fibronectin. The recombinant protein TSP18, corresponding to amino acid residues 1-174 of human platelet TSP, was purified from inclusion bodies as previously described (6) .
Human fibrinogen (Fg), depleted of von Willebrand factor and fibronectin, was from Enzyme Research Laboratories (South Bend, IN). Purified human-platelet GPIIbIIIa receptor was isolated from human platelet membranes by lentil lectin affinity chromatography followed by Sephacryl S-300 HR gel filtration chromatography and eluted from the column with an HSC buffer (in mM: HEPES 5, NaCl 150, CaCl 2 3, pH 7.4) containing 30 mM of β-OG (n-octyl-β-D-glucopyranoside) (31 Washed platelets (WP) were prepared from platelet rich plasma (PRP) by the "single centrifuging and dilution procedure" described by Goldsmith et al (35) . Briefly, blood was taken from healthy volunteers, not on any medication, added into 3.8% sodium citrate (1:9 vol/vol blood), followed by centrifugation (150 x g, 15 min). PRP was removed and acidified to pH 6.5 with 0.1% citric acid and ZK 36 374 was added to 50 nM followed by centrifugation (800 x g for 15 min). The platelet pellet was gently re-dispersed and resuspended in Ca 2+ -free modified Tyrode buffer containing 0.35% (w/v) BSA, pH 7.4 (BAT buffer) and kept at 37°C.
GPIIbIIIa-activated and fixed platelets (AFP)
were prepared according to Du et al (36) with modifications as previously reported (37 nM TSP, and sheared for 0-60 s at 300 s -1 . These studies were compared to beads prepared with 5% Fg-receptor occupancy which yield maximal kinetics of aggregation, as previously reported (34) Aggregation in flow. Kinetics of aggregations of AFP or GPIIbIIIa*-beads and/or ligands (Fg, TSP) were determined in a microcouette, as previously described (34, 37) . Briefly, suspensions (400 µl) were loaded in the gap between the two cylinders at a fixed shear rate (G) (34), was determined from experimentally measured initial rate of beads or AFP removal into bead-bead or AFP-AFP doublet formation, as previously described (34, 37) .
Aggregation of AFP during incubation with soluble Fg or Fg plus TSP was negligible, as confirmed by phase-contrast microscopy (Zeiss, 500x magnification). Moreover, we did not detect disappearance of platelets or beads from the samples due to adhesion to the walls of the microcouette during shear.
TSP-beads coaggregate during storage at 4°C to partially form doublets and triplets (with no significant higher multiplets) : ~23% and 13% respectively (mean of 15 measurements) of the total number of particles at time 0 of the shear. We corrected for this effect on calculated α by modifying our equations as previously described (34) .
Data analysis. Data are expressed as mean ± SE (standard error of the mean). To fit the nonlinear equations to our data, we used a nonlinear regression curve-fitter software (Sigma Plot, Jandel Scientific Software, San Rafael, CA), as previously described (37) . 
RESULTS
Interactions of TSP and TSP18 with Fg-beads
Aggregation of Fg-GPIIbIIIa*-beads by TSP.
We next determined the capacity for soluble TSP to form cross-bridges between receptor-bound Fg, in the absence of direct Fg cross-bridging to free GPIIbIIIa* receptors. For this experiment, GPIIbIIIa*-beads were first decorated by irreversibly bound Fg (Fg-GPIIbIIIa*-beads) and the free receptors were blocked by the RGD mimetic Ro 44-9883 (see inset in Figure 7 ). Thus, without TSP ( Figure 7A ), the aggregation of Fg-GPIIbIIIa*-beads was almost completely inhibited by Ro 44-9883 (PA = 13.6 ± 4.4%, after 120 s of shear rate at 300 s -1 ). However, in presence of reproduced the experiment using Fg bound to activated fixed platelets (Fg-AFP) instead of Fg-GPIIbIIIa*-beads ( Figure 7B ). As explained in the Experimental Procedures, only ~ 5% of surface-expressed activated GPIIbIIIa* on AFP remained occupied by Fg molecules in the presence of 1 µΜ Ro 44-9883. Thus, with all free GPIIbIIIa* blocked by Ro 44-9883, no aggregation of Fg-AFP occurred in the absence of TSP, but added TSP induced 12.5 ± 7.1% aggregation by 120 s of shear at 300 s -1 , with a related aggregation efficiency of 1.9 ± 0.2%. The TSP/Fg ratio measured at the surface of the platelets was the same as on Fg-GPIIbIIIa* beads (10-15%), corresponding here to a TSP surface density of 4-5 molecules/µm 2 (n=3).
Effect of the addition of TSP on aggregation efficiency of Fg-GPIIbIIIa*-beads at low receptor occupancy (0.5%)
Fg-GPIIbIIIa*-beads were prepared at low receptor occupancy (0.5%), in a range where aggregation efficiency varies rapidly with percent occupancy, previously reported to be between 0-20% for platelets (37) and 0-5% for our model beads (34) . Incubation of these beads with 180 nM of TSP gave a partial decoration of bound Fg by TSP (10-15% of the bound Fg). In the presence of TSP, the kinetics of aggregation at 300 s -1 was slowed down, corresponding to a decrease of α of ~30%, from 16.9 ± 0.1 % to 12.0 ± 1.2 % (figure 8).
Effect of the addition of TSP on aggregation efficiency of AFP by Fg
We first varied the Fg-receptor occupancy at a fixed shear rate of 300 s -1 . AFP were incubated with Fg or Fg plus TSP (molar ratio of 1:4) to yield Fg-GPIIbIIIa* occupancies of 3-6%, 20% and 35% with about 10-15% of Fg occupied by TSP. Aggregation efficiencies (α) for AFP sheared with Fg only, increased from 9 to 20% with increasing Fg receptor occupancy from 3-6% to 35% ( Table 1 ). The addition of TSP induced a significant increase of α at all Fg-receptor occupancies tested (p<0.01 to p<0.07), with mean increases ranging from 30 to 61% (Table 1) .
We next varied the shear rate at a fixed receptor occupancy of 20%. Thus, AFP were incubated with Fg (20 nM) or Fg plus TSP (20/80 nM) for 30 min. In the absence of TSP, α decreased 15-fold when increasing the shear rate from 300 to 2000 s -1 . The addition of TSP induced a significant increase of α at both 300 and 2000 s -1 (p<0.1) and an increase of 30% was also observed at 1000 s -1 (p<0.3) ( Table 2) .
Interactions of TSP with TSP-beads. Soluble FITC-TSP could bind to TSP immobilized on polystyrene latex beads
(TSP-beads) with a Kd of 732 ± 118 nM ( Figure 9 ). Aggregate formation mediated by TSP-TSP interaction(s) was 12 investigated in flow by shearing TSP-beads from 100 to 2000 s -1 in the microcouette ( Figure 10A ). TSP-beads
coaggregated at all shear rates tested. The extent of aggregation after 120 s of shear increased with increasing shear rate from 100 to 300 s -1 ( 59 ± 3% and 77 ± 3%, respectively), but decreased at higher shear rates (67 ± 0.4% and 49 ± 3% at 1000 and 2000 s -1 , respectively). The calculated related α indicated that the high efficiency of TSP-beads coaggregation at 100 s -1 (22.2 ± 4.9%) decreased by about 10-fold and 40-fold at 1000 and 2000 s -1 , respectively ( Figure 10B ). When TSP-beads were sheared at 300 s -1 in the presence of 8 mM EDTA, both PA ( Figure 10A ) and α were reduced by >80% and >90% respectively. TSP-beads did not aggregate either with Fg-beads or GPIIbIIIa*-beads (results not shown). 
DISCUSSION
We studied the involvement of thombospondin-1 (TSP) in platelet aggregation through its interaction with fibrinogen (Fg) bound to its receptor, the activated GPIIbIIIa integrin (GPIIbIIIa*). We used model particles, either latex beads with surface-adsorbed Fg (Fg-beads) or Fg bound to surface-captured GPIIbIIIa* (Fg-GPIIbIIIa*-beads), or activated fixed platelets (AFP) bearing GPIIbIIIa* with bound Fg (Fg-AFP). These models were chosen to mimic the surface of activated platelets but in the absence of any signalling or secretion process, thereby isolating the cross- Nevertheless, when testing the effect of addition of TSP on the aggregation efficiency of AFP mediated by
Fg and GPIIbIIIa*, we found an increase of 30-110% at all Fg-receptor occupancies (3-35%) and all shear rates (300-2000 s -1 ) tested, with 10-15% of receptor-bound Fg decorated by TSP. We expect that TSP-Fg associations on the cell surface would accelerate the kinetics of aggregation (i.e. aggregation efficiency) by 1) increasing the length of the bridges which will both increase the surface area available for cross-bridging (see figure 11) , and decrease the actual distance required for cell-cell interactions, thereby increasing the collision frequency, 2) increasing the 15 number of bridges between the platelets, and 3) concentrating adhesive molecules in multivalent adhesive structures (clusters) that will favour firm platelet to platelet adhesion (see below).
In addition to Fg-TSP-Fg interactions, we have shown that TSP-TSP interactions can also participate in cross-bridging to drive particle aggregation at varying shear rates. The beads co-aggregated at all shear rates, with a 10-fold decrease in efficiency for a 10-fold increase in shear rate (100-1000 s -1 ), similar to the 5-fold decrease previously reported for Fg-mediated aggregation of ADP-activated platelets driven by GPIIbIIIa*-Fg cross-bridges (37) . The maximal aggregation efficiency at 300 s -1 (10.4 ± 1.2%) was only 2-3 times lower than for Fg-mediated aggregation of particles or platelets with surface-bound GPIIbIIIa* (34, 37 and this study).
Our work demonstrates the direct contribution of TSP in reinforcing the inter-platelet interactions in physiological flow conditions. The participation of TSP is thought to be maximal during the early phase of the platelet secretion process when high concentrations of TSP may accumulate at the contact of activated platelets with
Fg already bound to a significant number of GPIIbIIIa*. Expected TSP-mediated cross-bridges are modelled in ). This latter model may appear controversial because platelets from patients with Glanzmann's thrombastenia (GT) which lack GPIIbIIIa, have been shown to express normal levels of TSP at the cell surface upon thrombin activation, with no aggregation detected in an aggregometer (23, 47) . However, this apparent contradiction with our model may rather arise from the facts that 1) micro-aggregates of <10 platelets observed in one GT patient by phase contrast microscopy may not be detected by aggregometry (48) , and 2) electron microscopy studies revealed that upon thrombin activation, TSP was not distributed normally on the platelet surface of one GT patient, with decreased size and number of TSP clusters (49) . It is therefore conceivable that in absence of GPIIbIIIa (and membrane-bound Fg), TSP may not be in an "efficient clustered" conformation to support platelet cross-bridging. Our model of coaggregation of TSP-beads is expected to circumvent these experimental artefacts as 1) our experimental setting detects micro-aggregates as small as doublets, and 2) we used TSP-beads with high TSP-surface density (2347 ± 424 molecules per µm 2 ) that possibly mimic the concentrated TSP found in clusters.
Finally our model suggests that macromolecular TSP/Fg/GPIIbIIIa* associations could also form, with TSP and sheared at 300 s -1 . Beads prepared with 5% Fg-receptor occupancy (t) were sheared in parallel as a control for maximal aggregation. Mean ± SE of three experiments. Inset: schematic representation describing the assay.
: Fg; : TSP; : GPIIbIIIa*.
FIGURE 9
Binding isotherm of FITC-TSP to TSP-beads. FITC-TSP (0 to 500 nM) was incubated with TSP-beads (l) or BSAbeads (m) (non specific binding) for 1 h at RT in the dark. Results, expressed as the number of FITC-TSP molecules bound per bead, are the mean ± SE of three experiments.
FIGURE 10
Coaggregation of TSP-beads. TSP-beads (10,000/µl), in BAT buffer supplemented with 1 mM CaCl 2 , were sheared with varying the shear rate from 100 s -1 to 2000 s -1 . TSP-beads were also sheared at 300 s -1 in the presence of 8 mM EDTA (preincubated with the beads 1 min before the shear). Results, expressed as percentages of aggregated platelets (A) or aggregation efficiencies (B), are the means ± SE of at least three separate experiments. 26   TABLE 1   TABLE 2 by guest on July 10, 2017
